🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
120 Servings
Other Combinations Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

0.338 mg (20% DV)
✅ Within RDA (0.3× RDA of 1.3 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 0.338mg UL 100mg
2.5 mg
📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)
This product: 2.5mg UL 10mg

Other Ingredients

Sorbitol Magnesium Stearate Corn Syrup, Solids Contains less than 2% of

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free Dairy Free

Product Information

📋 Directions for Use

DIRECTIONS: As a dietary supplement, adults should allow one tablet to dissolve under the tongue at bedtime.

⚠️ Warnings & Precautions

This product is not intended for children. Keep out of the reach of children.

Warning: If you are under medical supervision or are taking tranquilizers or sedatives, seek the advice of your physician prior to using melatonin. Do not use melatonin if you have an autoimmune condition, depressive or endocrine disorder, or are pregnant or lactating.

Do not take melatonin while operating a motor vehicle or machinery. Not to be taken by individuals under the age of 18.

Do not use if inner seal is missing or broken.

🧪 Formulation Notes

Promotes a restful night's sleep

Gluten free

Contains no: Milk/Dairy, eggs, fish, shellfish, tree nuts, peanuts, wheat, soy, gluten, or gelatin.

Additional Information

basic's

Store in a dry, controlled room environment.

Product Details

UPC / SKU 3 07610 15224 3
DSLD Entry Date 2021-07-27
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 250359
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →